Hyperforin - A key constituent of St. John's wort specifically activates TRPC6 channels

FASEB Journal

Volumn 21, Issue 14, 2007, Pages 4101-4111

  Leuner, Kristina ^a   Kazanski, Victor ^b   Müller, Margarethe ^a   Essin, Kirill ^b   Henke, Bettina ^a   Gollasch, Maik ^b   Harteneck, Christian ^b   Müller, Walter E ^a  

^a Pharmakologisches Institut für Naturwissenschaftler   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Calcium; Neurite outgrowth

Indexed keywords

CALCIUM; HYPERFORIN; PROTEIN TRPC 6 CHANNEL; SODIUM; TRANSIENT RECEPTOR POTENTIAL CHANNEL C; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL GROWTH; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; HYPERICUM PERFORATUM; NEURITE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; BICYCLO COMPOUNDS; CALCIUM; CELL LINE; DEPRESSION; GENE EXPRESSION REGULATION; HUMANS; HYPERICUM; PC12 CELLS; PHLOROGLUCINOL; PLANT EXTRACTS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SODIUM; TERPENES; TRPC CATION CHANNELS;

EID: 36849071263     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.07-8110com     Document Type: Article

References (39)

1. Müller, W. E. (2003) Current St John's wort research from mode of action to clinical efficacy. Pharmacol. Res. 47, 101-109
2. Williams, J. W., and Jr., Holsinger, T. (2005) St John's for depression, worts and all. BMJ 330, E350-E351
3. Szegedi, A., Kohnen, R., Dienel, A., and Kieser, M. (2005) Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine. BMJ 330, 503
4. Lecrubier, Y., Clerc, G., Didi, R., and Kieser, M. (2002) Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial. Am.J. Psychiatry. 159, 1361-1366
5. Kasper, S., Anghelescu, I. G., Szegedi, A., Dienel, A., and Kieser, M. (2006) Superior efficacy of St John's wort extract WS 5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial. BMC Med. 4, 14
6. Linde, K., Mulrow, C. D., Berner, M., and Egger, M. (2005) St John's wort for depression. Cochrane. Database. Syst. Rev. CD000448
7. Wonnemann, M., Singer, A., and Müller, W. E. (2000) Inhibition of synaptosomal uptake of 3H-L-glutamate and 3H-GABA by hyperforin, a major constituent of St. John's Wort: the role of amiloride sensitive sodium conductive pathways. Neuropsychopharmacology 23, 188-197
8. +. J. Pharmacol. Exp. Ther. 290, 1363-1368
9. Treiber, K., Singer, A., Henke, B., and Müller, W. E. (2005) Hyperforin activates nonselective cation channels (NSCCs). Br. J. Pharmacol. 145, 75-83
10. Montell, C., Birnbaumer, L., and Flockerzi, V. (2002) The TRP channels, a remarkably functional family. Cell 108, 595-598
11. Clapham, D. E. (2003) TRP channels as cellular sensors. Nature 426, 517-524
12. Harteneck, C. (2005) Function and pharmacology of TRPM cation channels. Naunyn-Schmiedebergs. Arch. of. Pharmacol. 371, 307-314
13. Harteneck, C., Grimm, C., Kraft, R., and Schultz, G. (2005) Activation of TRPM3 by sphingosine. Naunyn-Schmiedebergs Arch. Pharmacol. 371, R54
14. Kraft, R., and Harteneck, C. (2005) The mammalian melastatin-related transient receptor potential cation channels: an overview. Plügers Arch. 451, 204-211
15. Riccio, A., Medhurst, A. D., Mattei, C., Kelsell, R. E., Calver, A. R., Randall, A. D., Benham, C. D., and Pangalos, M. N. (2002) mRNA distribution analysis of human TRPC family in CNS and peripheral tissues. Mol. Brain. Res. 109, 95-104
16. Kunert-Keil, C., Bisping, F., Kruger, and J., Brinkmeier, H. (2006) Tissue-specific expression of TRP channel genes in the mouse and its variation in three different mouse strains. BMC Genomics. 7, 159
17. Li, Y., Jia, Y. C., Cui, K., Li, N., Zheng, Z. Y., Wang, Y. Z., and Yuan, X. B. (2005) Essential role of TRPC channels in the guidance of nerve growth cones by brain-derived neurotrophic factor. Nature 434, 894-898
18. Wang, G. X., and Poo, M. M. (2005) Requirement of TRPC channels in netrin-1-induced chemotropic turning of nerve growth cones. Nature 434, 898-904
19. Greka, A., Navarro, B., Oancea, E., Duggan, A., and Clapham, D. E. (2003) TRPC5 is a regulator of hippocampal neurite length and growth cone morphology. Nat. Neurosci. 6, 837-845
20. Hofmann, T., Obukhov, A. G., Schaefer, M., Harteneck, C., Gudermann, T., and Schultz, G. (1999) Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol. Nature 397, 259-263
21. Grimm, C., Kraft, R., Sauerbruch, S., Schultz, G., and Harteneck, C. (2003) Molecular and functional characterization of the melastatin-related cation channel TRPM3. J. Biol. Chem. 278, 21493-21501
22. 2+ of agonist-stimulated divalent cation entry from the refilling of the agonist-sensitive intracellular pool. J. Biol. Chem. 265, 678-684
23. Vazquez, G., Wedel, B. J., Aziz, O., Trebak, M., and Putney, J. W., Jr. (2004) The mammalian TRPC cation channels. Biochim. Biophys. Acta 1742, 21-36
24. Hofmann, T., Schaefer, M., Schultz, G., and Gudermann, T. (2002) Subunit composition of mammalian transient receptor potential channels in living cells. Proc. Natl. Acad. Sci. U. S. A. 99, 7461-7466
25. Hellwig, N., Albrecht, N., Harteneck, C., Schultz, G., and Schaefer, M. (2005) Homo- and heteromeric assembly of TRPV channel subunits. J. Cell Sci. 118, 917-928
26. Large, W. A. (2002) Receptor-operated Ca2(+)-permeable nonselective cation channels in vascular smooth muscle: a physiologic perspective. J. Cardiovasc. Electrophysiol. 13, 493-501
27. Hisatsune, C., Kuroda, Y., Nakamura, K., Inoue, T., Nakamura, T., Michikawa, T., Mizutani, A., and Mikoshiba, K. (2004) Regulation of TRPC6 channel activity by tyrosine phosphorylation. J. Biol. Chem. 279, 18887-18894
28. Jung, S., Mühle, A., Schaefer, M., Strotmann, R., Schultz, G., and Plant, T. D. (2003) Lanthanides potentiate TRPC5 currents by an action at extracellular sites close to the pore mouth. J. Biol. Chem. 278, 3562-3571
29. Biber, A., Fischer, H., Römer, A., and Chatterjee, S. S. (1998) Oral bioavailability of hyperforin from hypericum extracts in rats and human volunteers. Pharmacopsychiatry 31, Suppl. 1, 36-43
30. Keller, J. H., Karas, M., Müller, W. E., Volmer, D. A., Eckert, G. P., Tawab, M. A., Blume, H. H., Dingermann, T., and Schubert-Zsilavecz, M. (2003) Determination of hyperforin in mouse brain by high-performance liquid chromatography/ tandem mass spectrometry. Anal. Chem. 75, 6084-6088
31. 2+ channel in PC12 cells (an adrenal chromaffin cell line) correlates with expression of the TRP-6 (transient receptor potential) protein. Biochem. J. 358, 717-726
32. Mwanjewe, J., and Grover, A. K. (2004) Role of transient receptor potential canonical 6 (TRPC6) in non-transferrin-bound iron uptake in neuronal phenotype PC12 cells. Biochem. J. 378, 975-982
33. (i) responses to G-protein coupled receptor activation in recombinantly TRPC5-expressed rat pheochromocytoma (PC12) cells. Neuroscience Letters 358, 161-164
34. Kim, J. Y., Saffen, D. (2005) Activation of M1 muscarinic acetylcholine receptors stimulates the formation of a multiprotein complex centered on TRPC6 channels. J. Biol. Chem. 280, 32035-32047
35. Caraveo, G., van Rossum, D. B., Patterson, R. L., Snyder, S. H., and Desiderio, S. (2006) Action of TFII-I outside the nucleus as an inhibitor of agonist-induced calcium entry. Science 314, 122-125
36. Strubing, C., Krapivinsky, G., Krapivinsky, L., and Clapham, D. E. (2003) Formation of novel TRPC channels by complex subunit interactions in embryonic brain. J. Biol. Chem. 278, 39014-39019
37. Strubing, C., Krapivinsky, G., Krapivinsky, L., and Clapham, D. E. (2001) TRPC1 and TRPC5 form a novel cation channel in mammalian brain. Neuron 29, 645-655
38. Li, H. S., Xu, X. Z., and Montell, C. (1999) Activation of a TRPC3-dependent cation current through the neurotrophin BDNF. Neuron. 24, 261-273
39. Duman, R. S. (2004) Depression: A case of neuronal life and death? Biol. Psychiatry. 56, 140-145